Table S4 from TNIK Inhibition Sensitizes TNIK-Overexpressing Lung Squamous Cell Carcinoma to Radiotherapy
Year: 2024
Type: other
Abstract: Synergy scores obtained from LSCC cell lines treated with NCB-0846 in combination with cisplatin/etoposide with NCB-0846 as the pretreatment. Cell viability was evaluated 48h after the addition of cisplatin/etoposide.
Authors: Triet Nguyen, Francesca A. Carrieri, Nick Connis, Audrey Lafargue, Jinhee Chang, Aaron Chan, Amol C. Shetty, Yang Song, Tung Hoang, Shreya Jagtap, Dipanwita D. Chowdhury, Muhammad A. Khan, Kathleen L. Gabrielson, Mohammad Rezaee, Pedro Torres-Ayuso, John Brognard, Christine L. Hann, Phuoc T. Tran
Language: English
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4401204268